Welcome To The HIV Academy
Open Menu
Reset Password
This web-portal is provided by Gilead as a professional service to the medical community. Information related to any product(s) may not be consistent with the local prescribing information. Please consult the full local prescribing information for approved information on any products discussed in this web-portal and before prescribing.
Reporting suspected adverse reactions after authorization of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable in your country.
Adverse reactions may also be reported directly to the manufacturer of the suspected product.
Adverse reactions related to Gilead products may be reported directly to Gilead via Drugsafety.dubai@gilead.com.
Please rotate your device and view this website in landscape